Parallel Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$32.4 - $68.18 $64 - $136	2 New	2 $0
Q1 2022 Apr 28, 2022	SELL	$25.68 - $35.59 $10,503 - $14,556	-409 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$24.9 - $40.26 $224 - $362	9 Added 2.25%	409 $12,000
Q2 2021 Aug 06, 2021	SELL	$32.46 - $43.42 $811 - $1,085	-25 Reduced 5.88%	400 $14,000
Q1 2021 Apr 23, 2021	SELL	$38.94 - $50.85 $3,971 - $5,186	-102 Reduced 19.35%	425 $17,000
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $4,781 - $8,098	127 Added 31.75%	527 $23,000
Q1 2020 Apr 27, 2020	SELL	$41.72 - $87.2 $792 - $1,656	-19 Reduced 4.53%	400 $20,000
Q4 2019 Jan 30, 2020	SELL	$45.7 - $81.86 $3,701 - $6,630	-81 Reduced 16.2%	419 $33,000
Q3 2019 Nov 01, 2019	SELL	$45.35 - $57.91 $9,070 - $11,582	-200 Reduced 28.57%	500 $24,000
Q2 2019 Aug 05, 2019	BUY	$52.6 - $63.29 $10,520 - $12,658	200 Added 40.0%	700 $37,000
Q4 2018 Feb 05, 2019	SELL	$31.54 - $46.67 $6,308 - $9,334	-200 Reduced 28.57%	500 $20,000
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $15,840 - $26,360	-400 Reduced 36.36%	700 $34,000
Q3 2017 Nov 15, 2017	BUY	$25.1 - $31.05 $27,610 - $34,155	1,100 New	1,100 $43,000
Q3 2017 Nov 14, 2017	SELL	$25.1 - $31.05 $27,610 - $34,155	-1,100 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	1,100	1,100 $29,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.